- Academic Editor
-
-
-
Background: Alzheimer’s disease
(AD) is a chronic neurodegenerative brain disorder currently without satisfactory
therapeutic treatments. Triggering receptors expressed on a myeloid cells-2
(Trem2) gene mutation has been reported as a powerful AD risk factor
that induces Trem2 gene deletion aggravated microglia disfunction and
Amyloid-
